GAMMAGARD LIQUID is indicated as a maintenance therapy to improve muscle strength and disability in adult patients with Multifocal Motor Neuropathy (MMN). GAMMAGARD LIQUID for MMN is for intravenous use only.
![GAMMAGARD LIQUID [Immune Globulin Infusion (Human)] 10% logo.](/content/experience-fragments/takeda/gammagard/us/en/hcp/mmn/header---mmn/master/_jcr_content/root/container_1325140548/container_6852551/container/image.coreimg.svg/1755842420057/logo-gammagard-white.svg){kind=logo}
Support for your patients with MMN
MMN=Multifocal Motor Neuropathy.
Resources for your office
To support your efforts in meeting patient needs, we’ve created a resource library full of helpful materials for you. You’ll also find helpful information you can pass along to your MMN patients and their loved ones.
Product Characteristics Brochure
Not all IVIG formulations are interchangeable.1 In this brochure, you’ll find GAMMAGARD LIQUID information related to formulation, dosage, infusion rate, and packaging along with patient risk conditions and risk factors to consider with IVIG administration.
Clinical Overview Brochure
This overview contains information on the study design, results, safety profile, and infusion experience for GAMMAGARD LIQUID’s clinical trial in MMN.
Patient education can play an important role in chronic disease management
Patient education is a vital component in caring for patients with chronic disease because it informs and involves patients in understanding both the disease state and the care instructions necessary for their condition. It also helps patients understand any lifestyle changes that they will need to make to help manage their condition.
Use this brochure to help patients explore treatment with GAMMAGARD LIQUID and to provide an overview of the infusion process, working with a specialty pharmacy, and more.
MMN Electrodiagnostic Testing Overview
For your patients who need electrodiagnostic testing, this resource helps them understand what to expect during the procedure and why testing is important.
Third-party links for MMN patients
An MMN diagnosis can bring a range of emotions, from confusion to relief. Many patients and their loved ones benefit from connecting with support from patient organizations.
The GBS/CIDP Foundation International*
This organization provides support for patients with several related conditions—including MMN—and provides help finding treatment specialists and ways to connect with other patients.
Neuropathy Action Foundation* (NAF)
This helpful organization posts brochures, news, and quarterly newsletters and provides information on navigating insurance.
The Foundation for Peripheral Neuropathy*
You’ll find lists of foundation-recommended neurologists and get to explore patient support groups.
American Association of Neuromuscular and Electrodiagnostic Medicine*
The American Association of Neuromuscular and Electrodiagnostic Medicine is a nonprofit association dedicated to improving the quality of medical care provided to people with muscle and nerve disorders.
Caregiver Action Network (CAN)*
Caregiver Action Network is an organization that works to improve the quality of life for the millions of Americans who care for loved ones with chronic conditions, disabilities, disease, or the frailties of old age.
*This organization is a third-party resource and not associated with Takeda.
How is GAMMAGARD LIQUID manufactured?
Every step of the process, from collection to manufacturing and delivery, ensures reliable, well-controlled, and high safety margins.1
References:
- Gelfand EW. Differences between IVIG products: impact on clinical outcome. Int Immunopharmacol. 2006;6(4):592-599.
- Poelsler G, Berting A, Kindermann J, et al. A new liquid intravenous immunoglobulin with three dedicated virus reduction steps: virus and prion reduction capacity. Vox Sang. 2008;94:184-192.
- GAMMAGARD LIQUID [Immune Globulin Infusion (Human)] 10%. Prescribing Information. Takeda Pharmaceuticals U.S.A., Inc.; 2024.